Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9078 USD | -2.39% | -2.97% | -36.09% |
May. 13 | Transcript : Lucid Diagnostics Inc., Q1 2024 Earnings Call, May 13, 2024 | |
May. 13 | Lucid Diagnostics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Lucid Diagnostics Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Lucid Diagnostics Inc.
Cantor Fitzgerald | |
Needham & Co. | |
BTIG | |
Canaccord Genuity | |
Ascendiant Capital |
EPS Revisions
- Stock Market
- Equities
- LUCD Stock
- Consensus Lucid Diagnostics Inc.